Results 181 to 190 of about 1,113 (191)

Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients

Graefe's Archive for Clinical and Experimental Ophthalmology, 2021
Anne Studsgaard, Mette Slot Nielsen
exaly  

Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study

Ophthalmology and Therapy, 2017
Theodoros Empeslidis, Vasileios Konidaris, Somnath Banerjee   +2 more
exaly  

ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Literature

Therapeutic Delivery, 2018
Maged S Habib
exaly  

Micro-implant d’acétonide de fluocinolone (ILUVIEN®) pour l’œdème maculaire diabétique chronique

Journal Francais D'Ophtalmologie, 2015
F Behar-Cohen
exaly  

Fluocinolonacetonid (Iluvien®-Implantat) in der Behandlung des strahlenbedingten Makulaödems im Langzeitverlauf

2021
Zimmermann, L, Kneifel, C, Grajewski, L, Krause, L   +3 more
openaire   +1 more source

Iluvien Implantation for Uveitis and Uveitic Macular Edema

Ocular Immunology and Inflammation, 2018
Ashvini K Reddy, Bryn M Burkholder
exaly  

Iluvien™: a new sustained delivery technology for posterior eye disease

Expert Opinion on Drug Delivery, 2008
Antonio Cutino
exaly  

The treatment of diabetic macular oedema (DMO) in UK real-life clinical practice with ILUVIEN® (fluocinolone acetonide) – its impact on current clinical practice

Expert Review of Ophthalmology, 2017
exaly  

Langzeitergebnisse bei der Behandlung der strahleninduzierten Makulopathie mit Fluocinolonacetonid (Iluvien®)

2022
Zimmermann, L, Grajewski, L, Kneifel, C, Krause, L   +3 more
openaire   +1 more source

ILUVIEN in Diabetic Macular Edema: The Choice of Second-Line Corticosteroid Should Be Left to the Clinical Judgement of the Treating Physician

Ophthalmologica, 2017
openaire   +2 more sources